Colorectal cancer, which affects the colon (large intestine) or rectum, is one of the most widespread cancers globally and carries serious health risks, even leading to death. The risk grows significantly with age, particularly impacting individuals aged 50 and above. This cancer develops as a result of uncontrolled cell development in the colon or rectum, which is also known as colon cancer. It is frequently caused by polyps, which are abnormal growths that can develop into cancer over time.
Early diagnosis through screenings increases the chance of successful treatment. Colorectal cancer treatments may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, depending on the stage and type of cancer.
Interested in learning more about participation in our clinical research studies? Determine your eligibility by responding to a brief set of inquiries. By completing the form below, you grant us permission to connect with you via phone, text, or email, offering further details through our research team.
If these health challenges disrupt your daily routine, you might be eligible for a clinical research opportunity. Feel free to reach out by filling out the form provided or giving us a call. Once you've submitted, one of our specialized team members at Biopharma will promptly get in touch with you.